Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • nico_z
    Junior Member
    • Mar 2013
    • 2

    #1

    Bowtie alignment for ChIP-seq: good alignment for input but not for ChIP sample

    Dear all,
    I carried out a ChIP-seq experiment for which I have fastq files for both the input and the ChIPped DNA. As expected, I reckon, the input sample produced many more reads than the ChIP sample. The former also have a better quality than the latter. After trimming (to remove the low-quality 3' ends of the reads) I'm left with 35 n-long sequences. If I align these reads to my reference genome using bowtie (bowtie -n 3 -l 35 --tryhard --best) the % of reads with at least one reported alignment is 96% for my Input DNA but only 45% for my ChIPped DNA. Is this normal? Or am I missing something?

    Thanks for your help.

    Nico
  • FWOS
    Epigenomics NGS Beast
    • Oct 2010
    • 17

    #2
    Can be Normal

    Hi Nico,

    Your results seem normal to me. On average, One can expect to map 40 - 60% of the IP'd reads. I have seen less than 10% mapping back, which was actually due to salmon sperm blockers contaminating the IP'd sample, but 45% is not too terrible.

    It really depends on the mark you are looking at, and the specificity of the antibody that you used to target it. Since the Input looked good it does not seem to be an issue with fragmentation. Although you need to remember that the histone could have been damaged and/or the IP'd sample may not have been fully de-crosslinked.

    Overall it does not sound like your experiment failed.

    Best,
    F

    Comment

    • nico_z
      Junior Member
      • Mar 2013
      • 2

      #3
      Thanks

      Thanks, that helped. After some additional analysis I found that many of the unmatched reads, for whatever reason (I'm guessing some form of contamination) nicely align to the Penicillium chrysogenum genome.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      26 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      20 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      36 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      43 views
      0 reactions
      Last Post SEQadmin2  
      Working...